PHARMACEUTICALS: INDUSTRY STAKES OUT ITS POSITION ON FOOD SUPPLEMENTS.
The industry's European association, AESGP, says introducing legislation in this field is generally welcome. The draft Directive on Food Supplements shows "an overall balanced approach", it says. But it is concerned that the way the food supplements rule is drafted could create ambiguities over the scope - and lead to some of its members' products being taken off the market, even though they are considered acceptable at national level.In particular, the industry is seeking reassurances that the annexes listing acceptable ingredients for food supplements should not be interpreted as being exhaustive. "AESGP understands", it says, that the proposal "does not prohibit the sale of supplements containing ingredients that are not listed in Annexes I and II". In other words, AESGP maintains, "products that do not fall under the scope of the Directive can therefore continue to be sold provided they are covered by national regulations". Member States "should not remove existing products from the market", AESGP insists.The current lists in the annexes are too limited at present, the industry also complains. It wants them extending to take in "well-established vitamin and mineral supplements already on the market with the European Union/EEA", including minerals such as boron, nickel, silicon, tin, vanadium, calcium phosphate, selenium yeast, sodium metasilicate and copper oxide, as well as vitamin A and cholecalciferol.
|Printer friendly Cite/link Email Feedback|
|Comment:||PHARMACEUTICALS: INDUSTRY STAKES OUT ITS POSITION ON FOOD SUPPLEMENTS.|
|Article Type:||Brief Article|
|Date:||Sep 30, 2000|
|Previous Article:||MERGER CONTROL: EU SET TO APPROVE AOL/TIME WARNER, BUT BLOCK EMI/WARNER DEAL.|
|Next Article:||STATE AID: EU COURT REDUCES FRENCH BIOFUEL SUBSIDY TO BP RIVALS.|